PURPOSE OF REVIEW: Respiratory infections remain a major cause of morbidity among HIV-infected persons. Thus, knowledge of recent advances regarding HIV-associated opportunistic pneumonias is crucial for optimal care of HIV-infected persons. RECENT FINDINGS: Bacterial pneumonia is the most common HIV-associated opportunistic pneumonia in the USA and its incidence remains appreciable. Worldwide, tuberculosis dominates the clinical picture. The absence of rapid, affordable diagnostics for active and latent tuberculosis remains a major obstacle that must be overcome if the global epidemic is to be slowed. The specter of extensively drug resistant tuberculosis and its overlap with HIV infection highlight the importance of rapid diagnostics and the need for accessible drug susceptibility testing. Pneumocystis (carinii) jirovecii pneumonia appears to be a more common pneumonia among HIV-infected persons residing in developing countries than was previously appreciated. Similar to tuberculosis, the absence of available diagnostics in developing areas is a major obstacle to clinical care and epidemiologic studies. The critical care of HIV-infected persons is challenging. SUMMARY: Although tremendous advances have been made in our understanding of the management, treatment, and prevention of HIV and its associated respiratory infections, significant gaps remain. Thus, continued epidemiologic, clinical, and bench research is needed.
PURPOSE OF REVIEW: Respiratory infections remain a major cause of morbidity among HIV-infectedpersons. Thus, knowledge of recent advances regarding HIV-associated opportunistic pneumonias is crucial for optimal care of HIV-infectedpersons. RECENT FINDINGS: Bacterial pneumonia is the most common HIV-associated opportunistic pneumonia in the USA and its incidence remains appreciable. Worldwide, tuberculosis dominates the clinical picture. The absence of rapid, affordable diagnostics for active and latent tuberculosis remains a major obstacle that must be overcome if the global epidemic is to be slowed. The specter of extensively drug resistant tuberculosis and its overlap with HIV infection highlight the importance of rapid diagnostics and the need for accessible drug susceptibility testing. Pneumocystis (carinii) jirovecii pneumonia appears to be a more common pneumonia among HIV-infectedpersons residing in developing countries than was previously appreciated. Similar to tuberculosis, the absence of available diagnostics in developing areas is a major obstacle to clinical care and epidemiologic studies. The critical care of HIV-infectedpersons is challenging. SUMMARY: Although tremendous advances have been made in our understanding of the management, treatment, and prevention of HIV and its associated respiratory infections, significant gaps remain. Thus, continued epidemiologic, clinical, and bench research is needed.
Authors: Brendan Flannery; Richard T Heffernan; Lee H Harrison; Susan M Ray; Arthur L Reingold; James Hadler; William Schaffner; Ruth Lynfield; Ann R Thomas; Jianmin Li; Michael Campsmith; Cynthia G Whitney; Anne Schuchat Journal: Ann Intern Med Date: 2006-01-03 Impact factor: 25.391
Authors: Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland Journal: Lancet Date: 2006-11-04 Impact factor: 79.321
Authors: Ronan A M Breen; R F Miller; T Gorsuch; C J Smith; J Ainsworth; J Ballinger; L Swaden; I Cropley; M A Johnson; M C I Lipman Journal: J Infect Dis Date: 2006-04-04 Impact factor: 5.226
Authors: Alison Morris; Lawrence A Kingsley; Gena Groner; Irina P Lebedeva; Charles B Beard; Karen A Norris Journal: AIDS Date: 2004-03-26 Impact factor: 4.177
Authors: Alison Morris; Frank C Sciurba; Irina P Lebedeva; Andrew Githaiga; W Mark Elliott; James C Hogg; Laurence Huang; Karen A Norris Journal: Am J Respir Crit Care Med Date: 2004-04-29 Impact factor: 21.405
Authors: Anne Bourgarit; Guislaine Carcelain; Valerie Martinez; Caroline Lascoux; Veronique Delcey; Brigitte Gicquel; Eric Vicaut; Philippe H Lagrange; Daniel Sereni; Brigitte Autran Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Theresa D Feola; Cynthia A Bonville; Donald A Cibula; Sherly Jose; Geetha Nattanmai; Joseph B Domachowske; Manika Suryadevara Journal: Hum Vaccin Immunother Date: 2016-05-24 Impact factor: 3.452
Authors: Philippe M Hauser; Frédéric X Burdet; Ousmane H Cissé; Laurent Keller; Patrick Taffé; Dominique Sanglard; Marco Pagni Journal: PLoS One Date: 2010-12-20 Impact factor: 3.240
Authors: Sebastien Kenmoe; Jean Joel Bigna; Abdou Fatawou Modiyingi; Marie S Ndangang; Paul Alain Ngoupo; Fredy Brice N Simo; Serges Tchatchouang; Elvis Temfack; Richard Njouom Journal: J Clin Virol Date: 2019-06-28 Impact factor: 3.168